An early-phase trial found that a personalized vaccine targeted and destroyed cancer cells in nine patients with advanced kidney cancer, effectively wiping out the disease and keeping it at bay ...

Cancer vaccines harness the power of the immune system to stop tumors in their tracks. They work a little differently than ...

Results of IMNN-101 Proof-of-Concept study demonstrate persistent immunogenicity in trial participants and further validate PlaCCine® technology IMNN-101 induced 2- to 4-fold increase in neutralizing ...

About 60% of all cancer patients in the United States receive radiation therapy as part of their treatment. However, this ...

Researchers at Yale University in a small, yet to be published study found that Covid vaccines were linked to a rare ...

Recent positive lab confirmation of Smart mRNA functionality is a tremendous milestone for the Company. This marks a ...

Memorial Sloan Kettering Cancer Center researchers have found RNA neoantigen vaccines that generate long-lived, functional ...

Vaccines to treat cancers have been around since 2010, the first being approved for prostate cancer, and another in 2015 for ...

Results from a trial of an mRNA vaccine for pancreatic cancer have shown that the vaccine reduces the chance of the cancer ...

Pancreatic cancer is the 10th deadliest form of cancer in the United States, according to the National Cancer Institute.

A promising new mRNA-based vaccine for pancreatic cancer has shown potential in reducing the recurrence of the disease ...